| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dd0c85bcdd7ef71df136b1d0a008aa0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-75 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-865 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate |
2022-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76785924c16f38f2e5de770c5e85b36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a526f98bba885f77dc69a5e7ce98dbbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60281928e81e01b43ef8fcbb4249a96e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f8103babefd2543a72a01913bfd0851 |
| publicationDate |
2022-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022152914-A1 |
| titleOfInvention |
Cellular production of glycosylated products |
| abstract |
The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of cultivation of metabolically engineered cells. The present invention describes a method for the production of a glycosylated product derived from UDP- GIcNAc and comprising a di- or oligosaccharide that is composed of at least two different monosaccharide subunits by a cell as well as the separation of said glycosylated product from the cultivation. Furthermore, the present invention provides a metabolically engineered cell for production of a glycosylated product derived from UDP-GIcNAc and comprising a di- or oligosaccharide that is composed of at least two different monosaccharide subunits. The present invention also provides a cell excreting a di- or oligosaccharide out of the cell. |
| priorityDate |
2021-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |